Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Microbes might manage your cholesterol : Researchers
In the darkest parts of the world where light fails to block out the unfathomable bounty of the stars, look up. There are still fewer specks illuminating the universe than there are bacteria in the world, hidden from sight, a whole universe inside just one human gut.
- Read more about The Lancet Infectious Diseases: Study from Chinese city of Guangzhou provides key insights on how COVID-19 spreads in households
New modelling research, published in The Lancet Infectious Diseases journal, suggests the coronavirus (SARS-CoV-2) that causes COVID-19 may spread more easily among people living together and family members than severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS). The estimates are the first of their kind to quantify symptomless transmission.
- Read more about Loss of lipid-regulating gene fuels prostate cancer spread : Researchers
Caption : Cancer cells gobble up lipids. Prostate cells are stained with Oil-Red O to detect lipid droplets. Our work shows that redistribution of lipids from prostate cancer microenvironment triggers inflammation and drives prostate cancer metastasis. Credit : Nick (Jin-Yih) Low

Johns Hopkins Kimmel Cancer Center researchers from the Department of Radiation Oncology and Molecular Radiation Sciences identified a lipid-regulating protein that conveys what the researchers describe as "superpowers" onto prostate cancer cells, causing them to aggressively spread.
- Read more about Breakthrough in COVID-19 treatment with Dexamethasone
The NIHR-funded and supported study RECOVERY (Randomised Evaluation of COVid-19 thERapY) has today announced that the steroid dexamethasone has been identified as the first drug to improve survival rates in certain coronavirus patients.
12 June 2020

Treating cancer & other NCDs safe & critical while COVID vaccine expected

PHD Chamber of Commerce and Industry hosted a webinar on "Cancer Care during COVID Times: Tackling of NCDs" with august panelist from the medical fraternity including Dr. N Subramanian, Chairman, Health Committee, PHD Chamber and Director, Medical Services, Indraprastha Apollo Hospitals; Dr. Gopi Chand Khilnani, Chairman, Pulmonary, Critical Care and Sleep Medicine, PSRI Hospital; Dr. Amish Vora, Co-Founder, and Director, Medical Oncology, H.O.P.E. Oncology Clinic & Sr.
- Read more about Dr. Reddy's Lab wins right to sell Gilead’s Remdesivir in 127 countries including India
Dr. Reddy's Laboratories has entered into a non-exclusive Licensing Agreement with Gilead Sciences that will grant Dr. Reddy’s the right to register, manufacture and sell Gilead’s investigational drug, Remdesivir, a potential treatment for Covid-19, in 127 countries including India.
- Read more about Sun Pharma Inks pact with Hikma Pharmaceuticals for supply of new psoriasis drug in Middle East & North Africa
Sun Pharma's wholly-owned subsidiaries and Hikma Pharmaceuticals PLC (Hikma) have entered into an exclusive licensing and distribution agreement for ILUMYA™, an innovative biologic product, for the Middle East & North Africa (MENA) region.
- Read more about Johnson & Johnson to begin Phase 1/2a Clinical Trials of COVID-19 vaccine in July
Johnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant. Initially scheduled to begin in September, the trial is now expected to commence in the second half of July.
- Read more about Targeting SARS-CoV-2 Enzyme with Inhibitors
Schematic of the main protease of SARS CoV-2 (left), the protein residue network of the main protease of SARS CoV-2 (center), and a zoomed-in view of the region around the binding site as detected by Estrada (right). CREDIT: Ernesto Estrada

As the COVID-19 pandemic caused by the coronavirus SARS-CoV-2 continues to spread around the world, many researchers are studying epidemiological models to predict its propagation.
- Read more about Scientists develop indigenous nasopharyngeal swabs
In the current pandemic scenario, global supplies of nasopharyngeal (NP) swabs are not dependable resulting in supply chain delays, escalating prices and variable quality. CSIR-National Chemical Laboratory (CSIR-NCL), Pune, has developed an indigenous NP swab for collecting samples from the throat cavity of COVID-19 patients. The need for making available domestic technology for NP swabs was flagged by CSIR to NCL in mid-April.